Bristol-Myers Squibb
BMY
$46.86
Share price
0.04%
Change (1 day)
14.18%
Change (1 year)
Categories
Market capitalization of Bristol-Myers Squibb (BMY)
Market cap: $95.36 Billion USD
As of June 2025 Bristol-Myers Squibb has a market cap of $95.36 Billion USD. This makes Bristol-Myers Squibb the world's 198th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Bristol-Myers Squibb from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | $95.36 B | -18.48% |
| 2024 | $116.98 B | 12.05% |
| 2023 | $104.40 B | -31.75% |
| 2022 | $152.97 B | 10.54% |
| 2021 | $138.39 B | -1.27% |
| 2020 | $140.17 B | -1.99% |
| 2019 | $143.01 B | 69.42% |
| 2018 | $84.41 B | -15.83% |
| 2017 | $100.29 B | 2.69% |
| 2016 | $97.66 B | -14.52% |
| 2015 | $114.26 B | 17.1% |
| 2014 | $97.57 B | 11.88% |
| 2013 | $87.21 B | 64.19% |
| 2012 | $53.12 B | -11.04% |
| 2011 | $59.71 B | 32.73% |
| 2010 | $44.98 B | 4.26% |
| 2009 | $43.15 B | -6.24% |
| 2008 | $46.02 B | -12.08% |
| 2007 | $52.35 B | 1.38% |
| 2006 | $51.63 B | 14.83% |
| 2005 | $44.97 B | -9.84% |
| 2004 | $49.88 B | -10.1% |
| 2003 | $55.48 B | 22.68% |
| 2002 | $45.22 B | -54.81% |
| 2001 | $100.07 B | -30.72% |
| 2000 | $144.44 B | 13.6% |
| 1999 | $127.14 B | -4.45% |
| 1998 | $133.06 B | 41.58% |
| 1997 | $93.98 B | 72.32% |
| 1996 | $54.53 B |
End of Day market cap according to different sources
On Jun 20th, 2025 the market cap of Bristol-Myers Squibb was reported to be:
$95.37 Billion USD
$95.36 Billion USD
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $136.27 B | 42.90% | 🇺🇸 USA |
 Merck MRK | $198.52 B | 108.17% | 🇺🇸 USA |
 Eli Lilly LLY | $684.73 B | 618.02% | 🇺🇸 USA |
 Novartis NVS | $229.16 B | 140.30% | 🇨🇭 Switzerland |
 Sanofi SNY | $116.54 B | 22.21% | 🇫🇷 France |
 AstraZeneca AZN | $217.06 B | 127.62% | 🇬🇧 UK |
 Johnson & Johnson JNJ | $360.40 B | 277.93% | 🇺🇸 USA |
 AbbVie ABBV | $327.31 B | 243.23% | 🇺🇸 USA |
 Amgen AMGN | $155.57 B | 63.14% | 🇺🇸 USA |
 Biogen BIIB | $18.61 B | -80.48% | 🇺🇸 USA |